Apyx Medical Corp (APYX): Market Cap to Revenue

Symbol and logo of brand Bovie Medical (APYX)

Personnel stability within R&D and biomedicine ensures the protection of Apyx Medical technologies. The company's price-to-sales ratio confirms market resilience, where the 2.00 indicator determines the metric's magnitude. Expansion into Asia and new FDA approvals for Renuvion systems will drive growth, while aggressive sales hiring and RSU programs maintain the business's high competitiveness.

APYX Bovie Medical P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Apyx Medical (APYX)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:APYX Apyx Medical Corp
Core merchandise of Apyx Medical Corporation

The scaling of Apyx Medical (APYX) business through strategic alliances in aesthetic medicine is clearly reflected in the price-to-sales ratio. This metric correlates the issuer's current market capitalization with its total annual revenue. The calculation allows for the identification of asset overvaluation when the company's value grows faster than the actual income generated by Renuvion technologies. Consistent monitoring of this indicator protects the investor from purchasing an overheated asset prior to a potential correction.

Competitors of Apyx Medical

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|STRATA Skin Sciences, Inc. (SSKN) - P/S Multiple|Price-to-Revenue Ratio GlucoTrack, Inc.|nanovibronix.com - Price-to-Sales Ratio|Market Cap to Revenue VERO (Venus Concept Corp)|NUWE - Price to Sales|Aethlon Medical - Market Cap to Revenue|ASXC: Market Cap to Revenue Ratio|AVGR: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio BSGM (BioSig)|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Market Cap to Revenue Know Labs Corporation|NARI (Inari Medical, Inc.) - P/S Multiple|Price to Sales nevro.com NVRO|P/S Multiple RSLS|Silk Road Medical, Inc. - Market Cap to Revenue Ratio